Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
It is one of the highest pharmaceutical-grade whey protein isolates on the market today
Final thoughts Stopping GHK-Cu typically produces gradual benefit decline over 2-4 months without dramatic rebound effects or rapid reversal to pre-treatment baseline, with 30-40% of long-term users (6+ months treatment) maintaining 50-70% of peak improvements indefinitely while shorter-term users show greater regression toward baseline
This is something to discuss with a medical provider who understands the compound
The binding affinity of rodent URAT1 to uric acid is only 14% to 20% of human URAT1, and it shows an extremely weak response to URAT1 inhibitors [13-15]
The antioxidant and neuroprotective properties of DSIP have attracted growing research attention
